CDMOs offering Bioconjugation Services with Oligonucleotide
8 published
8 published CDMOs match Bioconjugation Services and Oligonucleotide.
Locations in this set include United States, China, Canada, India, Singapore, and United Kingdom.
Capabilities that show up most often in this set: CMC Analytical Development, Oligonucleotide Manufacturing, Process Development, API Synthesis & Manufacturing, and Quality Control Testing.
Matching companies
ADViRNAADViRNA provides oligonucleotide design, synthesis, and screening services with proprietary chemical modifications and conjugation technologies for therapeutic siRNA and ASO development.
BOC SciencesBOC Sciences is a custom lab chemical supplier offering bulk compounds, custom synthesis, cGMP manufacturing, analytical services, and specialized drug delivery and bioconjugation platforms for pharmaceutical and biotechnology clients.
Bio-Synthesis, Inc.Custom DNA, RNA, siRNA, and ASO oligonucleotide synthesis, custom peptide manufacturing, and project-specific bioconjugation. Support extends from research through analytical QC, process development, and scale-up.
Dalton Pharma ServicesHealth Canada–approved and FDA-inspected cGMP contract manufacturer offering integrated drug discovery, development, and manufacturing services including custom synthesis, API production, formulation development, and sterile fill-finish for vials, syringes, and cartridges.
GBI BiomanufacturingFull-service biologics CDMO offering integrated development and manufacturing services including cell banking, upstream/downstream processing, bioconjugation, aseptic fill-finish, and regulatory support for complex biopharmaceuticals.
PharmaronPremier life science CRO and CDMO offering integrated R&D and manufacturing across drug discovery, preclinical, clinical development, and commercialization for small molecules, biologics, and cell & gene therapies. 25,000+ employees across China, US, and UK.
PortonPorton is a global CDMO offering integrated manufacturing and development services across small molecules, peptides, oligonucleotides, biologics, and conjugates with specialized capabilities in flow chemistry, biocatalysis, and advanced therapies.
Syngene InternationalInnovation-led CRDMO offering integrated scientific services from early discovery through commercial manufacturing, with cGMP-compliant facilities, 5,200+ scientists, and a new 50,000-liter single-use bioreactor capacity in the U.S.
Markdown mirror: /explore/bioconjugation/oligonucleotide.md